 Tusharkanti Ghosh
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 4 | 2021 | 678 | 1.080 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 452 | 0.780 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 313 | 0.770 |
Why?
| | Computational Biology | 1 | 2025 | 644 | 0.680 |
Why?
| | Lupus Nephritis | 3 | 2025 | 63 | 0.670 |
Why?
| | Software | 1 | 2025 | 665 | 0.650 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1774 | 0.600 |
Why?
| | Data Interpretation, Statistical | 1 | 2020 | 363 | 0.560 |
Why?
| | Models, Theoretical | 1 | 2020 | 578 | 0.500 |
Why?
| | Immunophenotyping | 3 | 2025 | 318 | 0.460 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2025 | 900 | 0.370 |
Why?
| | Metabolome | 2 | 2021 | 350 | 0.290 |
Why?
| | Mass Spectrometry | 2 | 2021 | 739 | 0.270 |
Why?
| | Proteome | 2 | 2022 | 472 | 0.260 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 27 | 0.240 |
Why?
| | Transcriptome | 2 | 2022 | 971 | 0.240 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 95 | 0.230 |
Why?
| | Th17 Cells | 1 | 2025 | 108 | 0.210 |
Why?
| | Arthritis, Rheumatoid | 2 | 2025 | 1167 | 0.210 |
Why?
| | Interferons | 2 | 2022 | 202 | 0.210 |
Why?
| | Databases, Genetic | 2 | 2021 | 237 | 0.210 |
Why?
| | Common Variable Immunodeficiency | 1 | 2023 | 29 | 0.200 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3284 | 0.190 |
Why?
| | B-Lymphocytes | 2 | 2025 | 847 | 0.190 |
Why?
| | Blood | 1 | 2022 | 107 | 0.180 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2025 | 539 | 0.180 |
Why?
| | Precision Medicine | 1 | 2025 | 429 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 242 | 0.180 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.170 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1142 | 0.170 |
Why?
| | Kidney | 2 | 2025 | 1468 | 0.170 |
Why?
| | Algorithms | 2 | 2025 | 1704 | 0.160 |
Why?
| | Discriminant Analysis | 1 | 2020 | 37 | 0.160 |
Why?
| | Support Vector Machine | 1 | 2020 | 38 | 0.160 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 79 | 0.160 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 185 | 0.160 |
Why?
| | Decision Trees | 1 | 2020 | 93 | 0.160 |
Why?
| | Area Under Curve | 1 | 2020 | 314 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1091 | 0.150 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 455 | 0.140 |
Why?
| | ROC Curve | 1 | 2020 | 554 | 0.140 |
Why?
| | Monocytes | 1 | 2020 | 563 | 0.140 |
Why?
| | Tropomyosin | 1 | 2017 | 14 | 0.140 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 638 | 0.130 |
Why?
| | Mutation | 2 | 2025 | 3958 | 0.120 |
Why?
| | Myosin Heavy Chains | 1 | 2017 | 192 | 0.120 |
Why?
| | Drug Liberation | 1 | 2015 | 35 | 0.120 |
Why?
| | Histones | 1 | 2020 | 636 | 0.120 |
Why?
| | Databases, Factual | 1 | 2020 | 1357 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1040 | 0.100 |
Why?
| | Heart | 1 | 2017 | 655 | 0.100 |
Why?
| | Humans | 15 | 2025 | 137585 | 0.090 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 365 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 121 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2025 | 3556 | 0.090 |
Why?
| | Nanoparticles | 1 | 2015 | 481 | 0.080 |
Why?
| | Autoimmunity | 2 | 2025 | 908 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 842 | 0.080 |
Why?
| | HIV Infections | 1 | 2022 | 2836 | 0.070 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 13 | 0.060 |
Why?
| | Signal Transduction | 3 | 2025 | 5079 | 0.060 |
Why?
| | Biomarkers | 3 | 2021 | 4149 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 57 | 0.060 |
Why?
| | Granzymes | 1 | 2025 | 50 | 0.060 |
Why?
| | Interleukin-15 | 1 | 2025 | 98 | 0.060 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2025 | 115 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2025 | 455 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 2085 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2023 | 137 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2023 | 130 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 385 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2022 | 156 | 0.050 |
Why?
| | Middle Aged | 4 | 2025 | 33479 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 30 | 0.040 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 417 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.040 |
Why?
| | Citrullination | 1 | 2020 | 13 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3196 | 0.040 |
Why?
| | Lymphocytes | 1 | 2023 | 397 | 0.040 |
Why?
| | Female | 6 | 2025 | 73304 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 165 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 302 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 116 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 558 | 0.040 |
Why?
| | Adult | 4 | 2025 | 37929 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 656 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 390 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 192 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 1024 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2023 | 718 | 0.040 |
Why?
| | Male | 5 | 2025 | 67762 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2021 | 327 | 0.030 |
Why?
| | Autoantigens | 1 | 2020 | 430 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 415 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 513 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 621 | 0.030 |
Why?
| | Sarcomeres | 1 | 2017 | 96 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2833 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1622 | 0.030 |
Why?
| | RNA Precursors | 1 | 2017 | 154 | 0.030 |
Why?
| | RNA Splicing | 1 | 2017 | 269 | 0.030 |
Why?
| | Elastomers | 1 | 2015 | 27 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4295 | 0.030 |
Why?
| | Actins | 1 | 2017 | 416 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1111 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5757 | 0.030 |
Why?
| | Mice | 2 | 2025 | 17787 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1783 | 0.030 |
Why?
| | Aged | 2 | 2025 | 23961 | 0.030 |
Why?
| | Autoantibodies | 1 | 2020 | 1496 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 788 | 0.020 |
Why?
| | Polymers | 1 | 2015 | 490 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2199 | 0.020 |
Why?
| | Animals | 2 | 2025 | 36940 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 21513 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 13209 | 0.010 |
Why?
| | Child | 1 | 2023 | 21935 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|